Should It Be Easier or Harder to Use Unapproved Drugs and Devices?
In applying statutory safeguards, the FDA must not regulate investigational new products so stringently that a life-saving therapy is unavailable. But the agency must also protect dying patients from exploitation by unscrupulous or overzealous researchers. The balance between individual choice and p...
| Main Author: | |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Interlibrary Loan: | Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany) |
| Published: |
1986
|
| In: |
The Hastings Center report
Year: 1986, Volume: 16, Issue: 1, Pages: 17-23 |
| Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
